FDA Will Inspect Firms That Didn’t Participate In U.S.-Canada Program
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers that turned down FDA's offer to participate in its Pilot Multipurpose Audit Program (PMAP) will soon be inspected by the agency, CDRH's compliance chief says